Oops, you're using an old version of your browser so some of the features on this page may not be displaying properly.

MINIMAL Requirements: Google Chrome 24+, Mozilla Firefox 20+, Internet Explorer 11, Opera 15–18, Apple Safari 7, SeaMonkey 2.15-2.23

ESMO Preceptorship on Lung Cancer Manchester March 2019

06 - 08 Mar 2019

Manchester, United Kingdom

ESMO Preceptorship on Lung Cancer

Presentations (slides and webcasts) from all ESMO Preceptorship courses are open to all according to the presenters' agreement to release them.

The use of these presentations is for personal educational purposes only. ESMO thanks the authors for their generosity.

Meeting programme Next/upcoming meetings

Learning objectives

Screening and novel diagnostic modalities
Management of early NSCLC and use of adjuvant treatments, role of multi-modality treatment in locally advanced NSCLC and limited stage SCLC
Management of patients with actionable driver mutations and novel targeted agents for advanced NSCLC
Role of immune-checkpoint blockade for lung cancer, novel immunotherapies and treatment of NSCLC with oligometastatic disease
Systemic treatment of mesothelioma and SCLC
Role of supportive and palliative care for thoracic malignancies

Hide

There are 28 resources available

08 Mar 2019

Prophylactic cranial irradiation and role of thoracic RT for extensive stage SCLC

Presenter: Neil Bayman, UK

Session: Session 6 SCLC

Resources:

08 Mar 2019

Treatment of Extensive Stage SCLC

Presenter: M. Früh, CH

Session: Session 6 SCLC

Resources:

08 Mar 2019

Targeted Agents in SCLC

Presenter: P. Garrido, ES

Session: Session 6 SCLC

Resources:

08 Mar 2019

Treatment of Limited Stage SCLC

Presenter: D. Cobben, UK

Session: Session 6 SCLC

Resources:

08 Mar 2019

Participant Clinical Case Discussion: Multiple Nodule Stage III NSCLC

Presenter: A. Parmanade, PT

Session: Session 5 Locally Advanced NSCLC

Resources:

08 Mar 2019

Participant Clinical Case Discussion: Trastuzumab After Immunotherapy in a Patient Affected by an HER-2-Mutant Advanced Lung Adenocarcinoma

Presenter: G. Sartori, IT

Session: Session 5 Locally Advanced NSCLC

Resources:

08 Mar 2019

Participant Clinical Case Discussion: Acquired Resistance in EGFR Mutated Oncogene-Addicted NSCLC

Presenter: I. Konstantinou, CY

Session: Session 5 Locally Advanced NSCLC

Resources:

08 Mar 2019

Role of Surgery for N2 Disease

Presenter: P. E. Van Schil, BE

Session: Session 5 Locally Advanced NSCLC

Resources:

08 Mar 2019

Combined Modality Treatment for NSCLC with N2 Disease

Presenter: C. Chan, UK

Session: Session 5 Locally Advanced NSCLC

Resources:

08 Mar 2019

Treatment of Locally Advanced NSCLC in the Elderly

Presenter: D. Woolf, UK

Session: Session 5 Locally Advanced NSCLC

Resources: